These clinical characteristics had not been previously described in individuals with CCD, which suggests makes us think that it could be a more severe case, and this could represent an expansion of expression of the RUNX2 clinical phenotype–genotype association in CCD. The gene discussed is RUNX2; the disease is cleidocranial dysplasia 1.